CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-09 | PELLETIER SAUNDRA L Chief Executive Officer | Purchase | +45,249 | $2.28 | $103K | 906,137 |
| 2021-02-03 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award | +500,000 | 860,888 | ||
| 2021-02-03 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +700,000 | 700,000 | ||
| 2021-02-03 | Barrans Russell Chief Commercial Officer | Grant or award | +200,000 | 481,852 | ||
| 2021-02-03 | Barrans Russell Chief Commercial Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2021-02-03 | File Justin J. Chief Financial Officer | Grant or award | +200,000 | 458,168 | ||
| 2021-02-03 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2021-02-03 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award | +200,000 | 343,542 | ||
| 2021-02-03 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2021-02-03 | Culwell Kelly Chief Medical Officer | Grant or award | +200,000 | 315,451 | ||
| 2021-02-03 | Culwell Kelly Chief Medical Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2020-11-17 | File Justin J. Chief Financial Officer | Purchase | +7,760 | $2.17 | $17K | 258,168 |
| 2020-11-17 | Fitzpatrick Alexander A General Counsel and Secretary | Purchase | +9,090 | $2.20 | $20K | 143,542 |
| 2020-09-11 | Barrans Russell Chief Commercial Officer | Purchase | +3,000 | $2.08 | $6K | 279,052 |
| 2020-09-10 | Barrans Russell Chief Commercial Officer | Purchase | +1,000 | $2.71 | $3K | 276,052 |
| 2020-09-08 | PELLETIER SAUNDRA L Chief Executive Officer | Sale | −122,500 | $3.26 | $399K | 360,888 |
| 2020-07-08 | Barrans Russell Chief Commercial Officer | Shares withheld for taxes | −20,381 | $3.30 | $67K | 275,052 |
| 2020-06-17 | Rarick Lisa Dale Director | Purchase | +5,250 | $2.99 | $16K | 5,250 |
| 2020-06-15 | Hall William Walmsley Director | Purchase | +5,000 | $2.85 | $14K | 5,000 |
| 2020-06-15 | Hall William Walmsley Director | Purchase | +5,000 | $2.85 | $14K | 5,000 |
Page 3 of 20 · 383 trades